133 related articles for article (PubMed ID: 34787358)
1. Dose Dependent Effects of Fructose and Glucose on de novo Palmitate and Glycerol Synthesis in an Enterocyte Cell Model.
Steenson S; Shojaee-Moradie F; Lovegrove JA; Umpleby AM; Jackson KG; Fielding BA
Mol Nutr Food Res; 2022 Jan; 66(1):e2100456. PubMed ID: 34787358
[TBL] [Abstract][Full Text] [Related]
2. Determining contributions of exogenous glucose and fructose to de novo fatty acid and glycerol synthesis in liver and adipose tissue.
Silva JCP; Marques C; Martins FO; Viegas I; Tavares L; Macedo MP; Jones JG
Metab Eng; 2019 Dec; 56():69-76. PubMed ID: 31473320
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Fructose Feeding on Intestinal Triacylglycerol Production and De Novo Fatty Acid Synthesis in Humans.
Steenson S; Shojaee-Moradie F; B Whyte M; G Jackson K; Lovegrove JA; A Fielding B; Umpleby AM
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32549314
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans.
Beysen C; Ruddy M; Stoch A; Mixson L; Rosko K; Riiff T; Turner SM; Hellerstein MK; Murphy EJ
Am J Physiol Endocrinol Metab; 2018 Jul; 315(1):E126-E132. PubMed ID: 29558206
[TBL] [Abstract][Full Text] [Related]
5. A dual sugar challenge test for lipogenic sensitivity to dietary fructose.
Hudgins LC; Parker TS; Levine DM; Hellerstein MK
J Clin Endocrinol Metab; 2011 Mar; 96(3):861-8. PubMed ID: 21252253
[TBL] [Abstract][Full Text] [Related]
6. Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructose- compared to glucose-fed mice.
Nunes PM; Wright AJ; Veltien A; van Asten JJ; Tack CJ; Jones JG; Heerschap A
FASEB J; 2014 May; 28(5):1988-97. PubMed ID: 24500922
[TBL] [Abstract][Full Text] [Related]
7. Using total plasma triacylglycerol to assess hepatic
Hodson L; Parry SA; Cornfield T; Charlton C; Low WS; Green CJ; Rosqvist F
Ups J Med Sci; 2020 Aug; 125(3):211-216. PubMed ID: 32208800
[No Abstract] [Full Text] [Related]
8. Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.
Schwarz JM; Noworolski SM; Wen MJ; Dyachenko A; Prior JL; Weinberg ME; Herraiz LA; Tai VW; Bergeron N; Bersot TP; Rao MN; Schambelan M; Mulligan K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2434-42. PubMed ID: 25825943
[TBL] [Abstract][Full Text] [Related]
9. De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose.
Sanders FW; Griffin JL
Biol Rev Camb Philos Soc; 2016 May; 91(2):452-68. PubMed ID: 25740151
[TBL] [Abstract][Full Text] [Related]
10. De novo lipogenesis and stearoyl-CoA desaturase are coordinately regulated in the human adipocyte and protect against palmitate-induced cell injury.
Collins JM; Neville MJ; Hoppa MB; Frayn KN
J Biol Chem; 2010 Feb; 285(9):6044-52. PubMed ID: 20032470
[TBL] [Abstract][Full Text] [Related]
11. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men.
Faeh D; Minehira K; Schwarz JM; Periasamy R; Park S; Tappy L
Diabetes; 2005 Jul; 54(7):1907-13. PubMed ID: 15983189
[TBL] [Abstract][Full Text] [Related]
12. Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children With Obesity and Metabolic Syndrome.
Erkin-Cakmak A; Bains Y; Caccavello R; Noworolski SM; Schwarz JM; Mulligan K; Lustig RH; Gugliucci A
J Clin Endocrinol Metab; 2019 Jul; 104(7):3003-3011. PubMed ID: 30869790
[TBL] [Abstract][Full Text] [Related]
13. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32188593
[TBL] [Abstract][Full Text] [Related]
14. Hepatic De Novo Lipogenesis in Obese Youth Is Modulated by a Common Variant in the GCKR Gene.
Santoro N; Caprio S; Pierpont B; Van Name M; Savoye M; Parks EJ
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1125-32. PubMed ID: 26043229
[TBL] [Abstract][Full Text] [Related]
15. Dietary carbohydrates and fatty liver disease: de novo lipogenesis.
Chiu S; Mulligan K; Schwarz JM
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):277-282. PubMed ID: 29697539
[TBL] [Abstract][Full Text] [Related]
16. Fatty Acid Synthase Inhibitor TVB-2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities.
Syed-Abdul MM; Parks EJ; Gaballah AH; Bingham K; Hammoud GM; Kemble G; Buckley D; McCulloch W; Manrique-Acevedo C
Hepatology; 2020 Jul; 72(1):103-118. PubMed ID: 31630414
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study.
Stiede K; Miao W; Blanchette HS; Beysen C; Harriman G; Harwood HJ; Kelley H; Kapeller R; Schmalbach T; Westlin WF
Hepatology; 2017 Aug; 66(2):324-334. PubMed ID: 28470676
[TBL] [Abstract][Full Text] [Related]
18. Effects of Artemisia species on de novo lipogenesis in vivo.
Rood JC; Schwarz JM; Gettys T; Mynatt RL; Mendoza T; Johnson WD; Cefalu WT
Nutrition; 2014; 30(7-8 Suppl):S17-20. PubMed ID: 24985100
[TBL] [Abstract][Full Text] [Related]
19. Fructose drives de novo lipogenesis affecting metabolic health.
Geidl-Flueck B; Gerber PA
J Endocrinol; 2023 May; 257(2):. PubMed ID: 36753292
[TBL] [Abstract][Full Text] [Related]
20. Young, healthy South Asians have enhanced lipogenic sensitivity to dietary sugar.
Hudgins LC; Hugo JL; Enayat S; Parker TS; Artis AS; Levine DM
Clin Endocrinol (Oxf); 2017 Mar; 86(3):361-366. PubMed ID: 27988942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
